Matches in Wikidata for { <http://www.wikidata.org/entity/Q65545962> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q65545962 description "assaig clínic" @default.
- Q65545962 description "clinical trial" @default.
- Q65545962 description "clinical trial" @default.
- Q65545962 description "clinical trial" @default.
- Q65545962 description "clinical trial" @default.
- Q65545962 description "ensaio clínico" @default.
- Q65545962 description "ensayo clínico" @default.
- Q65545962 description "ensayu clínicu" @default.
- Q65545962 description "essai clinique" @default.
- Q65545962 description "klinisch onderzoek" @default.
- Q65545962 description "клінічне випробування" @default.
- Q65545962 name "Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine" @default.
- Q65545962 name "Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine" @default.
- Q65545962 type Item @default.
- Q65545962 label "Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine" @default.
- Q65545962 label "Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine" @default.
- Q65545962 prefLabel "Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine" @default.
- Q65545962 prefLabel "Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine" @default.
- Q65545962 P1050 Q65545962-19123AF7-ED4B-4136-B4E4-1E98E9D862AB @default.
- Q65545962 P1050 Q65545962-32F58D11-8229-4DA8-9F2D-6E9607391405 @default.
- Q65545962 P1050 Q65545962-86E09E4C-293F-4EE1-99C6-65FFE204A263 @default.
- Q65545962 P1132 Q65545962-7E000D1F-B2F9-45F7-A23D-A02DBE574153 @default.
- Q65545962 P1476 Q65545962-59C92080-F2F1-490A-A6DC-A41D137D1E4A @default.
- Q65545962 P17 Q65545962-41150102-1C8C-4472-B9A5-1DA5DACEF46F @default.
- Q65545962 P2899 Q65545962-BE227D34-294E-4AD2-9F9F-5B8B6FC5F482 @default.
- Q65545962 P3098 Q65545962-0D8D9822-3266-412B-B5A2-1A10B25F53B3 @default.
- Q65545962 P31 Q65545962-4EFDFB71-00C2-41ED-BDD9-1CC78F9CA065 @default.
- Q65545962 P4135 Q65545962-B8BDB488-9A2F-457C-A7BF-A8181B034613 @default.
- Q65545962 P580 Q65545962-E71A5217-CF2C-4EFE-B8AD-05CD03BA5B79 @default.
- Q65545962 P582 Q65545962-57849179-4192-4133-8EAA-4D8C6F32F18A @default.
- Q65545962 P6099 Q65545962-0B36B257-9007-4116-8166-E93358BAEC97 @default.
- Q65545962 P6153 Q65545962-706F9222-BE83-4BCB-8039-C64FB9168CBD @default.
- Q65545962 P8363 Q65545962-07781858-D81E-4AEE-98B6-613A5CC5CBEA @default.
- Q65545962 P859 Q65545962-68168B8B-7311-45D9-A512-999E8F2B4429 @default.
- Q65545962 P1050 Q131742 @default.
- Q65545962 P1050 Q157661 @default.
- Q65545962 P1050 Q6853 @default.
- Q65545962 P1132 "+143" @default.
- Q65545962 P1476 "Evaluate the Persistence of Immune Response of GSK Biologicals' TWINRIX™ ADULT, Administered According to 0,6 Month Schedule and 0,12 Month Schedule, in Volunteers Aged 12-15 Years Inclusive at the Time of First Vaccine Dose" @default.
- Q65545962 P17 Q408 @default.
- Q65545962 P2899 "+12" @default.
- Q65545962 P3098 "NCT00197171" @default.
- Q65545962 P31 Q30612 @default.
- Q65545962 P4135 "+15" @default.
- Q65545962 P580 "2003-09-01T00:00:00Z" @default.
- Q65545962 P582 "2003-12-01T00:00:00Z" @default.
- Q65545962 P6099 Q42824827 @default.
- Q65545962 P6153 Q212322 @default.
- Q65545962 P8363 Q78089383 @default.
- Q65545962 P859 Q212322 @default.